A novel computational method to predict hypoattenuated leaflet thickening post-transcatheter aortic valve replacement

Aniket Venkatesh1,2, Fateme Esmailie3, Noah Tregobov4,5

  • 1Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Ga.

Insights

A new AI pipeline predicts hypoattenuated leaflet thickening (HALT), a sign of blood clots after TAVR valve replacement, using pre-procedure CT scans. This tool aids in preventing valve dysfunction and improving patient outcomes.

Area of Science:

  • Cardiovascular Imaging and Interventions
  • Artificial Intelligence in Medicine
  • Biomedical Engineering

Background:

  • Hypoattenuated leaflet thickening (HALT) is a computed tomography (CT) finding post-transcatheter aortic valve replacement (TAVR) indicating bioprosthetic valvular thrombosis.
  • Current methods for predicting HALT are not standardized or validated, posing risks for bioprosthetic valve dysfunction and adverse patient outcomes.

Purpose of the Study:

  • To develop a novel, rapid, artificial intelligence (AI) and machine learning (ML)-driven computational pipeline for predicting HALT using preprocedural CT scans.

Main Methods:

  • The pipeline integrated pre-TAVR CT reconstruction and reduced order modeling for predicting postprocedural geometric parameters.
  • Automated left ventricle segmentation was employed to predict hemodynamic parameters.
  • Statistical and ML analyses were performed to derive HALT predictive metrics.

Main Results:

  • The pipeline achieved 84.40% accuracy and an AUC of 0.87 in predicting HALT.
  • Statistically significant relationships were found between HALT and peak systolic blood velocity, peak systolic blood flow, left ventricular ejection time, ejection volume, and right coronary height.
  • ML-derived metrics of neosinus circulation strongly correlated with HALT occurrence.

Conclusions:

  • A computational pipeline utilizing pre-TAVR CT scans can predict post-TAVR geometric and hemodynamic measurements indicative of HALT risk.
  • This predictive tool may enhance clinical decision-making and understanding of postprocedural thrombosis prevention.
Abstract